Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - CASH FROM OPERATIONS
Cash from Operations ABEO - Abeona Therapeutics Inc.
-37 M
LAST VALUE
24.93%
2 YEAR CAGR
1.10%
5 YEAR CAGR
-186.31%
10 YEAR CAGR